Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Valone

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
The Journal of Clinical Investigation|June 1, 1979
Specific inhibition of the polymorphonuclear leukocyte chemotactic response to hydroxy-fatty acid metabolites of arachidonic acid by methyl ester derivativesE J Goetzl, F H Valone, V N Reinhold, et al.
Infection and Immunity|November 1, 1990
Binding of viridans group streptococci to human platelets: a quantitative analysisP M Sullam, D G Payan, P F Dazin, et al.
Journal of Clinical Immunology|March 1, 1987
Preferential human eosinophil chemotactic activity of the platelet-activating factor (PAF) 1-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphocholine (AGEPC)C E Sigal, F H Valone, M J Holtzman, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 1, 1991
Synthesis of platelet activating factor by ocular tissue from inflamed eyesJ T Rosenbaum, R S Boney, J R Samples, et al.
The Journal of Infectious Diseases|August 1, 1984
Defective polymorphonuclear leukocyte chemotaxis in homosexual men with persistent lymph node syndromeF H Valone, D G Payan, D I Abrams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1990
Selective activation of human monocytes by the platelet-activating factor analog 1-O-hexadecyl-2-O-methyl-sn-glycero-3-phosphorylcholineJ K Rose, R A Debs, R Philip, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Technetium-99m labeled 50H.19 antibody fragments: interaction of the antibody with plateletsF H Valone, R B Stricker, P O Zamora, et al.
Cancer Journal (Sudbury, Mass.)|January 5, 2002
Dendritic cell-based treatment of cancer: closing in on a cellular therapyF H Valone, E Small, M MacKenzie, et al.
Journal of Clinical Immunology|September 1, 1984
Indomethacin enhances the proliferation of mitogen-stimulated T lymphocytes of homosexual males with persistent generalized lymphadenopathyF H Valone, D G Payan, D I Abrams, et al.
Immunology|August 1, 1979
The immunological generation of a platelet-activating factor and a platet-lytic factor in the ratF H Valone, D I Whitmer, W C Pickett, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
The Journal of Clinical Investigation|June 1, 1979
Specific inhibition of the polymorphonuclear leukocyte chemotactic response to hydroxy-fatty acid metabolites of arachidonic acid by methyl ester derivativesE J Goetzl, F H Valone, V N Reinhold, et al.
Infection and Immunity|November 1, 1990
Binding of viridans group streptococci to human platelets: a quantitative analysisP M Sullam, D G Payan, P F Dazin, et al.
Journal of Clinical Immunology|March 1, 1987
Preferential human eosinophil chemotactic activity of the platelet-activating factor (PAF) 1-0-hexadecyl-2-acetyl-sn-glyceryl-3-phosphocholine (AGEPC)C E Sigal, F H Valone, M J Holtzman, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|March 1, 1991
Synthesis of platelet activating factor by ocular tissue from inflamed eyesJ T Rosenbaum, R S Boney, J R Samples, et al.
The Journal of Infectious Diseases|August 1, 1984
Defective polymorphonuclear leukocyte chemotaxis in homosexual men with persistent lymph node syndromeF H Valone, D G Payan, D I Abrams, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 1, 1990
Selective activation of human monocytes by the platelet-activating factor analog 1-O-hexadecyl-2-O-methyl-sn-glycero-3-phosphorylcholineJ K Rose, R A Debs, R Philip, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1988
Technetium-99m labeled 50H.19 antibody fragments: interaction of the antibody with plateletsF H Valone, R B Stricker, P O Zamora, et al.
Cancer Journal (Sudbury, Mass.)|January 5, 2002
Dendritic cell-based treatment of cancer: closing in on a cellular therapyF H Valone, E Small, M MacKenzie, et al.
Journal of Clinical Immunology|September 1, 1984
Indomethacin enhances the proliferation of mitogen-stimulated T lymphocytes of homosexual males with persistent generalized lymphadenopathyF H Valone, D G Payan, D I Abrams, et al.
Immunology|August 1, 1979
The immunological generation of a platelet-activating factor and a platet-lytic factor in the ratF H Valone, D I Whitmer, W C Pickett, et al.
Pageof 6